--Company Continues to Execute on Core Business Model While Enhancing Value Proposition and Pipeline with Recent Transactions--
--Robust Pipeline Now Includes Four Fully Owned, Clinical-Stage Assets--
Read more at globenewswire.comAll information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
--Company Continues to Execute on Core Business Model While Enhancing Value Proposition and Pipeline with Recent Transactions--
--Robust Pipeline Now Includes Four Fully Owned, Clinical-Stage Assets--
Read more at globenewswire.com| Symbol | Last | Chg | %Chg |
|---|---|---|---|
| PRTG | 6.81 | -0.15 | -2.16% |
| Portage Biotech Inc Ord | |||